Serum Institute of India CEO, Adar Poonawalla, has said that the trials in India have not stopped even after AstraZeneca halted global trials of the vaccine after trial volunteer fell ill in the UK. The Serum Institute will be manufacturing the potential vaccine developed by Oxford University in collaboration with AstraZeneca.